BR100 Increased By (0.44%)
BR30 Increased By (1.39%)
KSE100 Increased By (0.62%)
KSE30 Increased By (0.61%)
BECO 5.49 No Change ▼ 0.00 (0%)
BML 56.00 Decreased By ▼ -0.76 (-1.34%)
BOP 35.41 Increased By ▲ 0.29 (0.83%)
CNERGY 8.20 Increased By ▲ 0.05 (0.61%)
DCL 11.55 Increased By ▲ 0.04 (0.35%)
FCCL 58.15 Increased By ▲ 1.40 (2.47%)
FCSC 5.15 No Change ▼ 0.00 (0%)
FFL 17.90 Increased By ▲ 0.02 (0.11%)
FNEL 1.25 No Change ▼ 0.00 (0%)
HUMNL 11.10 Decreased By ▼ -0.02 (-0.18%)
KEL 8.56 Increased By ▲ 0.14 (1.66%)
KOSM 6.75 Increased By ▲ 0.17 (2.58%)
MLCF 105.65 Increased By ▲ 2.35 (2.27%)
NBP 202.10 Increased By ▲ 1.92 (0.96%)
PACE 11.28 Decreased By ▼ -0.01 (-0.09%)
PAEL 44.42 Increased By ▲ 0.95 (2.19%)
PIAHCLA 28.66 Increased By ▲ 1.17 (4.26%)
PIBTL 18.75 Increased By ▲ 1.05 (5.93%)
PPL 248.10 Increased By ▲ 3.78 (1.55%)
PRL 35.35 Decreased By ▼ -0.08 (-0.23%)
PTC 66.15 Increased By ▲ 0.80 (1.22%)
SEARL 94.95 Increased By ▲ 1.63 (1.75%)
SSGC 32.04 Decreased By ▼ -0.90 (-2.73%)
TELE 8.93 Increased By ▲ 0.02 (0.22%)
THCCL 66.65 Decreased By ▼ -0.07 (-0.1%)
TPLP 10.76 Decreased By ▼ -0.07 (-0.65%)
TREET 25.22 Increased By ▲ 0.10 (0.4%)
TRG 64.21 Decreased By ▼ -0.69 (-1.06%)
WAVES 10.85 Decreased By ▼ -0.08 (-0.73%)
WTL 1.27 Increased By ▲ 0.02 (1.6%)
World

North Korea to receive Covid vaccine after making request

  • According to the report, the North is to receive the AstraZeneca-Oxford jab produced by the Serum Institute of India.
Published February 4, 2021 Updated February 4, 2021 05:27pm
By

SEOUL: North Korea has requested Covid-19 vaccines and is expected to receive nearly two million doses, according to the Gavi vaccine alliance, part of the WHO-backed Covax programme, although the isolated country has insisted it is virus-free.

It is the first official confirmation that the North has asked for international help, with the country's medical infrastructure is seen as woefully inadequate for dealing with any large-scale outbreak.

The Covax scheme, co-led by the Gavi alliance, will distribute 1.99 million doses to the North, according to Covax's interim distribution report released this week.

All countries receiving interim allocations of vaccines "have submitted requests for vaccines", a Gavi spokesman told AFP on Thursday.

The allocations cited in the report "reflect latest estimates of supply and take into account country readiness and regulatory approvals," he added.

According to the report, the North is to receive the AstraZeneca-Oxford jab produced by the Serum Institute of India.

Pyongyang closed its borders in late January last year -- the first country in the world to do so -- in a bid to protect itself against the coronavirus.

It has long insisted that it has had no cases, with its leader Kim Jong Un reiterating the claim at a huge military parade in October.

Experts suggest that is unlikely, given the virus first emerged in neighbouring China, its main provider of trade and aid.

Comments

Comments are closed for this article.